We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+9.96%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$264M
AUM Growth
+$27.7M
Cap. Flow
-$234M
Cap. Flow %
-88.6%
Top 10 Hldgs %
37.42%
Holding
144
New
Increased
Reduced
Closed
83

Top Buys

No buys this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 28.3%
2 Industrials 17.23%
3 Real Estate 9.7%
4 Technology 9.49%
5 Consumer Staples 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BECN
26
DELISTED
Beacon Roofing Supply, Inc.
BECN
0
NCNA
27
NuCana
NCNA
$5.58M
0
MGP
28
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
0
TWOU
29
DELISTED
2U Inc
TWOU
0
KTOS icon
30
Kratos Defense & Security Solutions
KTOS
$10.4B
0
CIC.U
31
DELISTED
Capitol Investment Corp. IV
CIC.U
0
IPOA.U
32
DELISTED
Social Capital Hedosophia Holdings Corp.
IPOA.U
0
ITCI
33
DELISTED
Intra-Cellular Therapies Inc.
ITCI
0
NITE
34
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
0
DCPH
35
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
0
ASND icon
36
Ascendis Pharma A/S
ASND
$16B
0
PETQ
37
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
0
TRTN
38
DELISTED
Triton International Limited
TRTN
0
EPZM
39
DELISTED
Epizyme, Inc
EPZM
0
TMHC
40
DELISTED
Taylor Morrison
TMHC
-100,000
Closed -$2.21M
ROKU icon
41
Roku
ROKU
$21.8B
0
NCLH icon
42
Norwegian Cruise Line
NCLH
$9.33B
0
ACRS icon
43
Aclaris Therapeutics
ACRS
$859M
-45,740
Closed -$1.23M
CLDR
44
DELISTED
Cloudera, Inc.
CLDR
0
OSPRU
45
DELISTED
Osprey Energy Acquisition Corp. Unit
OSPRU
0
DVAX
46
DELISTED
Dynavax Technologies
DVAX
0
NTB icon
47
Bank of N.T. Butterfield & Son
NTB
$2.46B
-83,614
Closed -$2.85M
ZAYO
48
DELISTED
Zayo Group Holdings, Inc.
ZAYO
0
OMP
49
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
0
BCRX icon
50
BioCryst Pharmaceuticals
BCRX
$2.29B
0

Similar funds

Monashee Investment Management's Q3 2017 Portfolio in Review

As of Q3 2017, Monashee Investment Management held 144 positions worth $264M, up 12% from $237M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Monashee Investment Management withdrew a net $234M in Q3 2017, closing 83 positions. Its most notable exit was Athene Holding Ltd. Class A Common Shares, an estimated $14.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 31% a quarter earlier, followed by Industrials and Real Estate.

  • Monashee Investment Management fully exited Athene Holding Ltd. Class A Common Shares in Q3 2017, selling an estimated $14.9M.
  • Monashee Investment Management's ten largest holdings make up 37% of its $264M portfolio in Q3 2017.
  • Monashee Investment Management opened 0 new positions and closed 83 in Q3 2017.
  • Monashee Investment Management's portfolio value rose 12% quarter-over-quarter to $264M.

Based on Monashee Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.